Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-28 Sale | 2024-10-29 6:33 pm | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 4,334 | $0.6902 | $2,991 | 30,423 (Direct) | View |
| 2024-10-28 Sale | 2024-10-29 6:27 pm | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 3,984 | $0.6901 | $2,749 | 75,885 (Direct) | View |
| 2024-10-28 Sale | 2024-10-29 6:26 pm | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 4,259 | $0.6901 | $2,939 | 133,414 (Direct) | View |
| 2024-10-28 Sale | 2024-10-29 6:24 pm | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 8,748 | $0.6901 | $6,037 | 165,082 (Direct) | View |
| 2024-10-28 Sale | 2024-10-29 6:23 pm | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 2,983 | $0.6901 | $2,059 | 88,483 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 5:48 pm | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 873 | $0.84 | $733 | 150,736 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 5:45 pm | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 973 | $0.84 | $817 | 50,701 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 5:42 pm | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 923 | $0.84 | $775 | 95,372 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 5:38 pm | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 2,518 | $0.84 | $2,115 | 224,118 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 5:36 pm | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 728 | $0.84 | $612 | 106,669 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 5:29 pm | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 1,128 | $0.84 | $948 | 107,263 (Direct) | View |
| 2024-08-05 Sale | 2024-08-06 4:15 pm | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 24,480 | $1.0839 | $26,534 | 78,178 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 8:23 pm | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 939 | $0.94 | $883 | 51,674 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 8:18 pm | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 2,435 | $0.94 | $2,289 | 226,636 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 8:18 pm | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 703 | $0.94 | $661 | 46,877 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 8:17 pm | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 891 | $0.94 | $838 | 96,295 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 8:16 pm | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 1,090 | $0.94 | $1,025 | 108,391 (Direct) | View |
| 2024-05-15 Sale | 2024-05-17 8:14 pm | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 843 | $0.94 | $792 | 151,609 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:48 pm | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 3,939 | $1.08 | $4,254 | 689,732 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:42 pm | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 11,549 | $1.08 | $12,473 | 1,795,401 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:31 pm | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 4,170 | $1.08 | $4,504 | 603,841 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:29 pm | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 3,374 | $1.08 | $3,644 | 554,235 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:21 pm | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 4,400 | $1.08 | $4,752 | 589,893 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:15 pm | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 5,010 | $1.08 | $5,411 | 616,136 (Direct) | View |
| 2024-02-16 Sale | 2024-02-16 9:13 pm | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 3,939 | $1.08 | $4,254 | 751,597 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 9:43 pm | Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks | 2,904 | $1.35 | $3,920 | 73,936 (Direct) | View |
| 2023-10-30 Sale | 2023-10-31 9:40 pm | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 8,552 | $1.35 | $11,545 | 199,132 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-27 Exercise | 2024-10-29 6:33 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 13,744 | $0 | 30,423 (Direct) | View |
| 2024-10-27 Exercise | 2024-10-29 6:27 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 12,622 | $0 | 75,885 (Direct) | View |
| 2024-10-27 Exercise | 2024-10-29 6:26 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 13,500 | $0 | 133,414 (Direct) | View |
| 2024-10-27 Exercise | 2024-10-29 6:24 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 27,837 | $0 | 165,082 (Direct) | View |
| 2024-10-27 Exercise | 2024-10-29 6:23 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 11,360 | $0 | 88,483 (Direct) | View |
Ownership | 2024-10-02 08:15 am | N/A N/A | Seres Therapeutics Inc. | MCRB | NESTLE SA Societe des Produits Nestle S.A. 10% Owner | 0 | $0 | 21,879,753 (Indirect) | View |
| 2024-08-15 Exercise | 2024-08-19 5:48 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 2,656 | $0 | 150,736 (Direct) | View |
| 2024-08-15 Exercise | 2024-08-19 5:45 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 2,969 | $0 | 50,701 (Direct) | View |
| 2024-08-15 Exercise | 2024-08-19 5:42 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 2,813 | $0 | 95,372 (Direct) | View |
| 2024-08-15 Exercise | 2024-08-19 5:38 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 7,813 | $0 | 224,118 (Direct) | View |
| 2024-08-15 Exercise | 2024-08-19 5:36 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 2,656 | $0 | 106,669 (Direct) | View |
| 2024-08-15 Exercise | 2024-08-19 5:29 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 2,969 | $0 | 107,263 (Direct) | View |
| 2024-08-03 Exercise | 2024-08-06 4:15 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 85,000 | $0 | 78,178 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 4:15 pm | N/A 2034-06-30 | Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director | 64,564 | $0 | 64,564 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 4:15 pm | N/A 2034-06-30 | Seres Therapeutics Inc. | MCRB | Graves Kurt Director | 64,564 | $0 | 64,564 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 4:15 pm | N/A 2034-06-30 | Seres Therapeutics Inc. | MCRB | Berenson Stephen Director | 114,782 | $0 | 114,782 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 8:23 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 2,968 | $0 | 51,674 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 8:18 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 7,812 | $0 | 226,636 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 8:18 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 2,656 | $0 | 46,877 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 8:17 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 2,812 | $0 | 96,295 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 8:16 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 2,968 | $0 | 108,391 (Direct) | View |
| 2024-05-15 Exercise | 2024-05-17 8:14 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 2,656 | $0 | 151,609 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Graves Kurt Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Kender Richard N Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Biondi Paul Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Fraser Claire Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Dere Willard H Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Ausiello Dennis A Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-04-04 Option Award | 2024-04-08 4:45 pm | N/A 2034-04-03 | Seres Therapeutics Inc. | MCRB | Berenson Stephen Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-03-25 Option Award | 2024-03-27 4:20 pm | N/A 2034-03-24 | Seres Therapeutics Inc. | MCRB | Thorell Marella See Remarks | 700,000 | $0 | 700,000 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:48 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 10,625 | $0 | 689,732 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:48 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | DesRosier Thomas Chief Legal Officer and EVP | 537,280 | $0 | 689,732 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:42 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 31,250 | $0 | 1,795,401 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:42 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 1,566,330 | $0 | 1,795,401 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:31 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 11,250 | $0 | 603,841 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:31 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | Henn Matthew R. See Remarks | 506,655 | $0 | 603,841 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:29 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 10,625 | $0 | 554,235 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:29 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | Young Teresa L. See Remarks | 506,655 | $0 | 554,235 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:21 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 11,875 | $0 | 589,893 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:21 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | von Moltke Lisa See Remarks | 537,280 | $0 | 589,893 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:15 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 11,875 | $0 | 616,136 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:15 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | Ege David S. See Remarks | 506,655 | $0 | 616,136 (Direct) | View |
| 2024-02-15 Exercise | 2024-02-16 9:13 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 10,625 | $0 | 751,597 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 9:13 pm | N/A 2034-02-13 | Seres Therapeutics Inc. | MCRB | Arkowitz David Chief Financial Officer | 537,280 | $0 | 751,597 (Direct) | View |
| 2023-10-27 Exercise | 2023-10-31 9:43 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks | 9,418 | $0 | 73,936 (Direct) | View |
| 2023-04-27 Option Award | 2023-10-31 9:43 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Cloghessy Paula See Remarks | 18,835 | $0 | 73,936 (Direct) | View |
| 2023-10-27 Exercise | 2023-10-31 9:40 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 27,838 | $0 | 199,132 (Direct) | View |
| 2023-04-27 Option Award | 2023-10-31 9:40 pm | N/A N/A | Seres Therapeutics Inc. | MCRB | Shaff Eric D. CEO and President | 55,675 | $0 | 199,132 (Direct) | View |